DRUG DELIVERY PLATFORMS

Epidel

Epidel Logo

ANTI-INFECTIVE POLYMERS

INNOVATIVE POLYMER COATING TECHNOLOGY THAT PROVIDES FOR THE SUSTAINED RELEASE OF ACTIVE ANTI-MICROBIAL AND/OR ANTI-INFLAMMATORY AGENTS DIRECTLY FROM A MEDICAL DEVICE

Interface biologics has demonstrated commercialization success with its surface modification technology and is well positioned to drive further incremental value with its drug delivery technology.

IBI’s Epidel™ anti-infective oligomers/polymers allow for pharmaceuticals to be coated directly onto the medical device providing for long term anti-microbial effectiveness. The technology is flexible and can provide solutions for multiple medical devices with different surface morphology and characteristics (e.g. mesh, polymeric, metallic) and manufacturing processes (e.g. coating, extrusion, heat press) and a broad range of compatible drugs.

ADVANTAGES

TECHNOLOGY ADVANTAGES
  • Ability to deliver a broad range of drugs/biologics
  • Does not impact drug mechanism of action
  • Does not impact device functionality
  • Simple chemistry = flexibility

PRODUCT APPLICATIONS

There are two active development projects using the Epidel technology:

1) an anti-microbial dental implant to address infection issues for both de novo implants as well as peri-implantitis (product extension opportunity: orthopedic fixation screws/plates)

2) a coated Dacron® cuff for peritoneal dialysis catheters, dialysis catheters and/or tunneled PICCs (product extension opportunity: hernia mesh)

Episcrew

EPISCREW
Anti-microbial dental implants and orthopedic fixation devices

Epicuff

EPICUFF
Coated percutaneous cuffs for dialysis catheters, tunneled PICCs and other applications

Powered by Innovasium